Insider trades

Todd Watanabe, Officer of Arcutis Biotherapeutics ARQT, has filed 3 purchases and 38 sales on the open market. Over the past 12 months that comes to a net sale of $5.2M. The latest trade was on 05/04.

Todd Watanabe

SEE REMARKS
First filing
23/03/02
Trades
67 trades
Buys / sales
3 / 38
12-month net buying
−$5.2M
Last trade
05/04

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan05/0405/063,172 sh$23.61$74,890.92−0.4%
ARQT
Open-market sale10b5-1 plan03/0203/0337,349 sh2 trades$25.18avg.$940,501.84−4.5%
Open-market sale10b5-1 plan02/0202/0419,833 sh$25.50$505,741.5−2.7%
ARQT
Open-market sale10b5-1 plan25/11/21–25/11/2425/11/2450,000 sh2 trades$30.35avg.$1,517,620.2−6.3%
ARQT
Open-market sale10b5-1 plan25/11/0325/11/0511,547 sh2 trades$24.71avg.$285,373.98−1.4%
Open-market sale10b5-1 plan25/10/2825/10/3040,000 sh$25.03$1,001,200−4.7%
ARQT
Open-market sale10b5-1 plan25/10/01–25/10/0225/10/0345,000 sh3 trades$19.66avg.$884,664.78−5.0%
ARQT
Open-market sale10b5-1 plan25/09/08–25/09/0925/09/1010,129 sh2 trades$17.54avg.$177,652.58−1.1%
Open-market sale10b5-1 plan25/08/0425/08/0511,547 sh$14.33$165,468.51−1.3%
Open-market sale10b5-1 plan25/05/0225/05/0511,448 sh$15.19$173,895.12−1.2%
ARQT
Open-market sale10b5-1 plan25/03/24–25/03/2525/03/263,671 sh2 trades$17.54avg.$64,402.76−0.4%
Open-market sale10b5-1 plan25/03/1725/03/201,200 sh$17.61$21,132−0.1%
ARQT
Open-market sale10b5-1 plan25/03/03–25/03/0425/03/0425,015 sh2 trades$13.07avg.$326,979.2−2.6%
Open-market sale10b5-1 plan25/02/0325/02/0419,301 sh$12.70$245,122.7−2.3%
Open-market sale10b5-1 plan24/12/2024/12/2315,000 sh$15.17$227,550−1.8%
ARQT
Open-market buy24/05/31–24/11/3024/12/036,038 sh2 trades$3.52avg.$21,250.18+0.7%
Open-market sale10b5-1 plan24/11/0424/11/0513,871 sh$8.68$120,400.28−1.6%
Open-market sale10b5-1 plan24/08/0224/08/0514,487 sh$9.02$130,672.74−1.7%
Open-market sale10b5-1 plan24/05/0224/05/0313,783 sh$8.74$120,463.42−1.6%
Open-market sale10b5-1 plan24/03/0424/03/0614,903 sh$11.12$165,721.36−1.7%